IFM Therapeutics
IFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases. IFM Therapeutics launched in 2015 in Cambridge, Massachusetts, based on seed funding from the Boston-based venture capital fund Atlas Venture. The company's founding involved seven people, a mix of executives and university professors. Series A financing was provided by Atlas, London-based Abingworth, and Swiss pharmaceutical company Novartis.
Wikipage disambiguates
Link from a Wikipage to another Wikipage
primaryTopic
IFM Therapeutics
IFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases. IFM Therapeutics launched in 2015 in Cambridge, Massachusetts, based on seed funding from the Boston-based venture capital fund Atlas Venture. The company's founding involved seven people, a mix of executives and university professors. Series A financing was provided by Atlas, London-based Abingworth, and Swiss pharmaceutical company Novartis.
has abstract
IFM Therapeutics is a pharmace ...... ly bought by Novartis in 2019.
@en
former name
IFM (2016–2018)
@en
founding year
Wikipage page ID
61,224,622
page length (characters) of wiki page
Wikipage revision ID
1,017,928,487
Link from a Wikipage to another Wikipage
former name
IFM
@en
founded
in Cambridge, Massachusetts
@en
industry
Pharmaceutical
@en
key people
@en
Gary Glick
@en
Jean-Francoise Formela
@en
name
IFM Therapeutics, LLC
@en
subsid
IFM Due
@en
wikiPageUsesTemplate
subject
comment
IFM Therapeutics is a pharmace ...... armaceutical company Novartis.
@en
label
IFM Therapeutics
@en
sameAs
wasDerivedFrom
isPrimaryTopicOf
name
IFM Therapeutics, LLC
@en